Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarafidis

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Journal of the Cardiometabolic Syndrome|December 7, 2007
Thiazolidinediones and diabetic nephropathy: need for a closer examination?Pantelis A Sarafidis
Fundamental & Clinical Pharmacology|April 22, 2008
Thiazolidinedione derivatives in diabetes and cardiovascular disease: an updatePantelis A Sarafidis
Journal of Clinical Hypertension (Greenwich, Conn.)|July 19, 2011
Epidemiology of resistant hypertensionPantelis A Sarafidis
American Journal of Nephrology|January 11, 2018
Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?Pantelis A Sarafidis
Current Opinion in Nephrology and Hypertension|August 13, 2008
Obesity, insulin resistance and kidney disease risk: insights into the relationshipPantelis A Sarafidis
Journal of Hypertension|April 7, 2007
Metabolic syndrome and arterial stiffness: evidence for gender disparity and early effects of non-traditional risk factors?Pantelis A Sarafidis
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|July 16, 2015
Patient Cases: 1. A Patient with Apparent CompliancePantelis A Sarafidis
Minerva Medica|February 27, 2008
Proteinuria: natural course, prognostic implications and therapeutic considerationsP A Sarafidis
JAMA|November 10, 2011
Microscopic hematuria in adolescents and young adults and risk for end-stage renal diseasePantelis A Sarafidis
Clinical Kidney Journal|February 22, 2020
The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?Pantelis A Sarafidis, Alberto Ortiz
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Journal of the Cardiometabolic Syndrome|December 7, 2007
Thiazolidinediones and diabetic nephropathy: need for a closer examination?Pantelis A Sarafidis
Fundamental & Clinical Pharmacology|April 22, 2008
Thiazolidinedione derivatives in diabetes and cardiovascular disease: an updatePantelis A Sarafidis
Journal of Clinical Hypertension (Greenwich, Conn.)|July 19, 2011
Epidemiology of resistant hypertensionPantelis A Sarafidis
American Journal of Nephrology|January 11, 2018
Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?Pantelis A Sarafidis
Current Opinion in Nephrology and Hypertension|August 13, 2008
Obesity, insulin resistance and kidney disease risk: insights into the relationshipPantelis A Sarafidis
Journal of Hypertension|April 7, 2007
Metabolic syndrome and arterial stiffness: evidence for gender disparity and early effects of non-traditional risk factors?Pantelis A Sarafidis
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|July 16, 2015
Patient Cases: 1. A Patient with Apparent CompliancePantelis A Sarafidis
Minerva Medica|February 27, 2008
Proteinuria: natural course, prognostic implications and therapeutic considerationsP A Sarafidis
JAMA|November 10, 2011
Microscopic hematuria in adolescents and young adults and risk for end-stage renal diseasePantelis A Sarafidis
Clinical Kidney Journal|February 22, 2020
The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?Pantelis A Sarafidis, Alberto Ortiz
Pageof 21